跳至主要内容
临床试验/NCT01424137
NCT01424137已完成不适用

Inspiratory Flow Parameters With Placebo Dry Powder Inhalers, Easyhaler and Diskus; an Open, Randomised, Multicentre Study in Patients With Asthma or COPD

Orion Corporation, Orion Pharma5 个研究点 分布在 2 个国家目标入组 227 人开始时间: 2011年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
227
试验地点
5
主要终点
Peak inspiratory flow rate through the placebo Easyhaler and Diskus inhalers

研究概览

简要总结

The purpose of this study is to characterise inspiratory flow parameters across 2 Easyhaler® (EH) inhaler versions and Diskus® inhaler in patients with asthma (including children, adults, and the elderly) and in patients with chronic obstructive pulmonary disease (COPD).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
4 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Written informed consent (IC) obtained
  • •Documented diagnosis of asthma and/or COPD
  • •Age: 4 years and above

排除标准

  • •Any severe chronic respiratory disease other than asthma or COPD
  • •Acute respiratory infection
  • •Any medical condition that in the opinion of the investigator would endanger the subject if he/she participates in the study

研究组 & 干预措施

Easyhaler type A

Other

干预措施: Easyhaler type A (Device)

Easyhaler type B

Other

干预措施: Easyhaler type B (Device)

Diskus inhaler

Other

干预措施: Diskus inhaler (Device)

结局指标

主要结局

Peak inspiratory flow rate through the placebo Easyhaler and Diskus inhalers

时间窗: 1 day

次要结局

  • The inspiratory volume through the placebo Easyhaler and Diskus inhalers will be measured at the same time with the peak inspiratory flow rate(1 day)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验